471 related articles for article (PubMed ID: 15014952)
1. Relative importance of IL-4 and IL-13 in lesional skin of atopic dermatitis.
Tazawa T; Sugiura H; Sugiura Y; Uehara M
Arch Dermatol Res; 2004 Apr; 295(11):459-64. PubMed ID: 15014952
[TBL] [Abstract][Full Text] [Related]
2. The development of atopic dermatitis is independent of Immunoglobulin E up-regulation in the K14-IL-4 SKH1 transgenic mouse model.
Chen L; Overbergh L; Mathieu C; Chan LS
Clin Exp Allergy; 2008 Aug; 38(8):1367-80. PubMed ID: 18489026
[TBL] [Abstract][Full Text] [Related]
3. Enhanced expression levels of IL-31 correlate with IL-4 and IL-13 in atopic and allergic contact dermatitis.
Neis MM; Peters B; Dreuw A; Wenzel J; Bieber T; Mauch C; Krieg T; Stanzel S; Heinrich PC; Merk HF; Bosio A; Baron JM; Hermanns HM
J Allergy Clin Immunol; 2006 Oct; 118(4):930-7. PubMed ID: 17030248
[TBL] [Abstract][Full Text] [Related]
4. Down-regulation of IL-12 by topical corticosteroids in chronic atopic dermatitis.
Yawalkar N; Karlen S; Egli F; Brand CU; Graber HU; Pichler WJ; Braathen LR
J Allergy Clin Immunol; 2000 Nov; 106(5):941-7. PubMed ID: 11080718
[TBL] [Abstract][Full Text] [Related]
5. Overexpression of IL-10 in atopic dermatitis. Contrasting cytokine patterns with delayed-type hypersensitivity reactions.
Ohmen JD; Hanifin JM; Nickoloff BJ; Rea TH; Wyzykowski R; Kim J; Jullien D; McHugh T; Nassif AS; Chan SC
J Immunol; 1995 Feb; 154(4):1956-63. PubMed ID: 7836775
[TBL] [Abstract][Full Text] [Related]
6. Topical suplatast tosilate (IPD) ameliorates Th2 cytokine-mediated dermatitis in caspase-1 transgenic mice by downregulating interleukin-4 and interleukin-5.
Murakami T; Yamanaka K; Tokime K; Kurokawa I; Tsutsui H; Nakanishi K; Mizutani H
Br J Dermatol; 2006 Jul; 155(1):27-32. PubMed ID: 16792748
[TBL] [Abstract][Full Text] [Related]
7. Localization of interleukin-13 gene-expressing cells in tuberculin reactions and lesional skin from patients with atopic dermatitis.
van der Ploeg I; Matuseviciene G; Fransson J; Wahlgren CF; Olsson T; Scheynius A
Scand J Immunol; 1999 Apr; 49(4):447-53. PubMed ID: 10219773
[TBL] [Abstract][Full Text] [Related]
8. Unbalanced production of interleukin-5 and interleukin-2 in children with atopic dermatitis.
Yamamoto S; Hamasaki Y; Ishii E; Ichimaru T; Miyazaki S
Ann Allergy Asthma Immunol; 1997 May; 78(5):517-23. PubMed ID: 9164367
[TBL] [Abstract][Full Text] [Related]
9. Different cytokine production and activation marker profiles in circulating cutaneous-lymphocyte-associated antigen T cells from patients with acute or chronic atopic dermatitis.
Antúnez C; Torres MJ; Mayorga C; Cornejo-García JA; Santamaría-Babi LF; Blanca M
Clin Exp Allergy; 2004 Apr; 34(4):559-66. PubMed ID: 15080808
[TBL] [Abstract][Full Text] [Related]
10. Allergen challenge decreases mRNA expression of regulatory cytokines in whole blood of high-IgE beagles.
Maeda S; Tsuchida H; Marsella R
Vet Dermatol; 2007 Dec; 18(6):422-6. PubMed ID: 17991159
[TBL] [Abstract][Full Text] [Related]
11. Quantitative real-time RT-PCR measurement of cytokine mRNA expression in the skin of normal cats and cats with allergic skin disease.
Taglinger K; Van Nguyen N; Helps CR; Day MJ; Foster AP
Vet Immunol Immunopathol; 2008 Apr; 122(3-4):216-30. PubMed ID: 18191230
[TBL] [Abstract][Full Text] [Related]
12. T cells and mast cells as a major source of interleukin-13 in atopic dermatitis.
Obara W; Kawa Y; Ra C; Nishioka K; Soma Y; Mizoguchi M
Dermatology; 2002; 205(1):11-7. PubMed ID: 12145428
[TBL] [Abstract][Full Text] [Related]
13. Lesional skin in atopic dogs shows a mixed Type-1 and Type-2 immune responsiveness.
Schlotter YM; Rutten VP; Riemers FM; Knol EF; Willemse T
Vet Immunol Immunopathol; 2011 Sep; 143(1-2):20-6. PubMed ID: 21684616
[TBL] [Abstract][Full Text] [Related]
14. Therapeutic effects of streptococcal preparation OK-432 on atopic dermatitis-like lesions in NC/Nga mice: possible shift from a Th2- to Th1-predominance.
Horiuchi Y; Bae S; Katayama I; Nishioka K
J Dermatol Sci; 2004 Sep; 35(3):187-97. PubMed ID: 15381240
[TBL] [Abstract][Full Text] [Related]
15. The squamous cell carcinoma antigens as relevant biomarkers of atopic dermatitis.
Mitsuishi K; Nakamura T; Sakata Y; Yuyama N; Arima K; Sugita Y; Suto H; Izuhara K; Ogawa H
Clin Exp Allergy; 2005 Oct; 35(10):1327-33. PubMed ID: 16238792
[TBL] [Abstract][Full Text] [Related]
16. Epigallocatechin-3-gallate improves Dermatophagoides pteronissinus extract-induced atopic dermatitis-like skin lesions in NC/Nga mice by suppressing macrophage migration inhibitory factor.
Noh SU; Cho EA; Kim HO; Park YM
Int Immunopharmacol; 2008 Sep; 8(9):1172-82. PubMed ID: 18602062
[TBL] [Abstract][Full Text] [Related]
17. PPARgamma expression profile and its cytokine driven regulation in atopic dermatitis.
Dahten A; Mergemeier S; Worm M
Allergy; 2007 Aug; 62(8):926-33. PubMed ID: 17620071
[TBL] [Abstract][Full Text] [Related]
18. IL-31 is associated with cutaneous lymphocyte antigen-positive skin homing T cells in patients with atopic dermatitis.
Bilsborough J; Leung DY; Maurer M; Howell M; Boguniewicz M; Yao L; Storey H; LeCiel C; Harder B; Gross JA
J Allergy Clin Immunol; 2006 Feb; 117(2):418-25. PubMed ID: 16461143
[TBL] [Abstract][Full Text] [Related]
19. In vivo levels of IL-4, IL-10, TGF-beta1 and IFN-gamma mRNA of the peripheral blood mononuclear cells in patients with alopecia areata in comparison to those in patients with atopic dermatitis.
Katagiri K; Arakawa S; Hatano Y
Arch Dermatol Res; 2007 Jan; 298(8):397-401. PubMed ID: 17021766
[TBL] [Abstract][Full Text] [Related]
20. Expression of fractalkine and its receptor, CX3CR1, in atopic dermatitis: possible contribution to skin inflammation.
Echigo T; Hasegawa M; Shimada Y; Takehara K; Sato S
J Allergy Clin Immunol; 2004 May; 113(5):940-8. PubMed ID: 15131578
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
